https://hipa.ai/drug/atezolizumab/updates/trial-results-posted-nct06267001-2026-06-10 Hipa.ai en 2026-06-10T00:00:00.000Z Atezolizumab NSCLC Trial Terminated; Adverse Event Counts Posted https://hipa.ai/drug/nivolumab/updates/trial-results-posted-nct04879368-2026-06-10 Hipa.ai en 2026-06-10T00:00:00.000Z Nivolumab (RegoNivo) Misses OS Endpoint in Advanced Gastro-Oesophageal Cancer https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-er-label-2026-06-09 Hipa.ai en 2026-06-09T00:00:00.000Z Metformin Hydrochloride ER Label Receives Boxed Warning for Lactic Acidosis https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-09 Hipa.ai en 2026-06-09T00:00:00.000Z Tofacitinib Label Adds Boxed Warning for Serious Infections, Mortality https://hipa.ai/drug/trastuzumab-deruxtecan/updates/trial-results-posted-nct05113251-2026-06-09 Hipa.ai en 2026-06-09T00:00:00.000Z Enhertu Trial Reveals Distinct pCR Rates in HER2-positive Early Breast Cancer https://hipa.ai/drug/canagliflozin/updates/boxed-warning-revised-metformin-hydrochloride-label-2026-06-09 Hipa.ai en 2026-06-09T00:00:00.000Z Metformin Hydrochloride Boxed Warning Revised for Lactic Acidosis https://hipa.ai/drug/aficamten/updates/trial-results-posted-nct05767346-2026-06-09 Hipa.ai en 2026-06-09T00:00:00.000Z Aficamten for oHCM Shows Superior Peak Oxygen Uptake vs. Metoprolol https://hipa.ai/drug/orforglipron/updates/trial-results-posted-nct05936138-2026-06-09 Hipa.ai en 2026-06-09T00:00:00.000Z Orforglipron Phase 1 PK Study Shows Increased Exposure in Renal Impairment https://hipa.ai/drug/iptacopan/updates/boxed-warning-present-label-fabhalta-label-effective-2026-06-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z Fabhalta (Iptacopan) Label Receives Boxed Warning for Serious Infections https://hipa.ai/drug/bi-3000202/updates/trial-results-posted-nct05945888-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z BI 3000202 Phase 1 Study in Healthy Men Reports Safety and PK Food Effect https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct03516981-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z Pembrolizumab Combinations Show Varied ORR in Biomarker-Directed Advanced NSCLC https://hipa.ai/drug/tofacitinib/updates/boxed-warning-present-label-tofacitinib-label-effective-2026-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z Tofacitinib (Xeljanz) Label Adds Boxed Warning for Serious Risks https://hipa.ai/drug/pembrolizumab/updates/trial-results-posted-nct04895722-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z Pembrolizumab/Quavonlimab Shows Higher ORR in MSI-H Colorectal Cancer https://hipa.ai/drug/canagliflozin/updates/boxed-warning-present-label-metformin-hydrochloride-label-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z Metformin Hydrochloride Label Adds Boxed Warning for Lactic Acidosis https://hipa.ai/drug/dapagliflozin/updates/trial-results-posted-nct04965935-2026-06-08 Hipa.ai en 2026-06-08T00:00:00.000Z Dapagliflozin Reduces Systolic Blood Pressure in Kidney Transplant Recipients